Avenue Therapeutics, Inc. ATXI
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.51% | -26.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.98% | -25.24% | |||
| Operating Income | 0.98% | 25.24% | |||
| Income Before Tax | 0.72% | 4.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.72% | 4.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.72% | 1.97% | |||
| EBIT | 0.98% | 25.24% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.76% | 5.25% | |||
| Normalized Basic EPS | 0.76% | 25.48% | |||
| EPS Diluted | 0.76% | 5.25% | |||
| Normalized Diluted EPS | 0.76% | 25.48% | |||
| Average Basic Shares Outstanding | 0.04% | 3.44% | |||
| Average Diluted Shares Outstanding | 0.04% | 3.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||